Filing Flows › Adma Biologics (ADMA) › How it makes money
How Adma Biologics (ADMA) makes money
Adma Biologics (ADMA) made $141M of revenue in the third quarter 2026 (Q3 2026), +5% from a year earlier. Of every dollar of revenue, 71¢ was left as gross profit, 48¢ was left as operating profit, 35¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $141M | 100.0% |
| Cost of revenue | $41.2M | 29.2% |
| Gross profit | $99.9M | 70.8% |
| Operating expenses | $32.2M | 22.8% |
| Operating profit | $67.8M | 48.0% |
| Income tax | $15.7M | 11.1% |
| Net earnings | $49.9M | 35.4% |
| Operating cash flow | $17.4M | 12.3% |
| Free cash flow | $15.4M | 10.9% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $141M | +5% |
| Q2 2026 | $124M | +2% |
| Q1 2026 | $114M | -0.3% |
| Q4 2025 | $139M | +18% |
| Q3 2025 | $134M | +12% |
| Q2 2025 | $122M | +14% |
| Q1 2025 | $115M | +40% |
From Adma Biologics' 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does Adma Biologics make money?
Adma Biologics (ADMA) made $141M of revenue in the third quarter 2026 (Q3 2026), +5% from a year earlier. Of every dollar of revenue, 71¢ was left as gross profit, 48¢ was left as operating profit, 35¢ was left as net earnings.
What is Adma Biologics' profit margin?
Net earnings were $49.9M, 35.4% of revenue, in the third quarter 2026; the operating margin was 48.0%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.